Rhythm Pharmaceuticals (RYTM) News Today $100.82 +0.61 (+0.61%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$100.87 +0.05 (+0.05%) As of 10/10/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RYTM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Leo Wealth LLC Has $850,000 Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTMOctober 10 at 5:04 AM | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Receives "Sell (D-)" Rating from Weiss RatingsOctober 9, 2025 | marketbeat.comShould You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead?October 3, 2025 | insidermonkey.comHC Wainwright & Co. Maintains Rhythm Pharmaceuticals (RYTM) Buy RecommendationSeptember 29, 2025 | msn.comJMP Securities Maintains Rhythm Pharmaceuticals (RYTM) Market Outperform RecommendationSeptember 26, 2025 | msn.comRhythm Pharmaceuticals price target raised to $142 from $135 at Citizens JMPSeptember 25, 2025 | msn.comJMP Securities Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock PriceSeptember 25, 2025 | marketbeat.comRhythm Pharmaceuticals price target raised to $122 from $109 at Morgan StanleySeptember 24, 2025 | msn.comRhythm Pharmaceuticals, Inc. (RYTM) Discusses On Commercial Readiness For Acquired Hypothalamic Obesity Event Call (Transcript)September 24, 2025 | seekingalpha.comRhythm Pharmaceuticals, Inc. - Special CallSeptember 24, 2025 | seekingalpha.comRhythm Pharmaceuticals, Inc. (RYTM) Discusses on Commercial Readiness for Acquired Hypothalamic Obesity EventSeptember 24, 2025 | seekingalpha.comRhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $138.00 at The Goldman Sachs GroupSeptember 24, 2025 | marketbeat.com3 Stocks That May Be Undervalued By Up To 49%September 23, 2025 | finance.yahoo.comRhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Wedge Capital Management L L P NCSeptember 23, 2025 | marketbeat.comAssenagon Asset Management S.A. Has $15.04 Million Position in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 23, 2025 | marketbeat.comToth Financial Advisory Corp Takes $632,000 Position in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 22, 2025 | marketbeat.com2 Under-the-Radar Stocks That Could SoarSeptember 21, 2025 | fool.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 20, 2025 | marketbeat.comVoya Investment Management LLC Cuts Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 20, 2025 | marketbeat.comStrs Ohio Invests $980,000 in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 19, 2025 | marketbeat.comHarbor Capital Advisors Inc. Grows Stake in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 18, 2025 | marketbeat.comE. Ohman J or Asset Management AB Purchases Shares of 8,213 Rhythm Pharmaceuticals, Inc. $RYTMSeptember 18, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. $RYTM Shares Bought by Intech Investment Management LLCSeptember 17, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Rhythm Pharmaceuticals (RYTM)September 16, 2025 | theglobeandmail.comRhumbline Advisers Acquires 2,988 Shares of Rhythm Pharmaceuticals, Inc. $RYTMSeptember 15, 2025 | marketbeat.comBayforest Capital Ltd Buys Shares of 3,134 Rhythm Pharmaceuticals, Inc. $RYTMSeptember 14, 2025 | marketbeat.comSiren L.L.C. Makes New $14.70 Million Investment in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 13, 2025 | marketbeat.comAdvisors Asset Management Inc. Acquires 3,176 Shares of Rhythm Pharmaceuticals, Inc. $RYTMSeptember 13, 2025 | marketbeat.comVoleon Capital Management LP Takes Position in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 12, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. (RYTM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comCinctive Capital Management LP Sells 78,399 Shares of Rhythm Pharmaceuticals, Inc. $RYTMSeptember 8, 2025 | marketbeat.comTrexquant Investment LP Has $2.05 Million Holdings in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 7, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. $RYTM Shares Sold by American Century Companies Inc.September 7, 2025 | marketbeat.comCheckpoint Capital L.P. Boosts Stake in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 6, 2025 | marketbeat.comCormorant Asset Management LP Decreases Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 6, 2025 | marketbeat.comBanque Transatlantique SA Takes Position in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 5, 2025 | marketbeat.comRhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 52-Week High - Here's WhySeptember 5, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. $RYTM Shares Bought by ADAR1 Capital Management LLCSeptember 4, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Alkeon Capital Management LLCSeptember 4, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Frazier Life Sciences Management L.P.September 4, 2025 | marketbeat.comRhythm Pharmaceuticals, Inc. $RYTM Shares Sold by Baker BROS. Advisors LPSeptember 4, 2025 | marketbeat.comCubist Systematic Strategies LLC Buys New Shares in Rhythm Pharmaceuticals, Inc. $RYTMSeptember 4, 2025 | marketbeat.comPDT Partners LLC Purchases 58,612 Shares of Rhythm Pharmaceuticals, Inc. $RYTMSeptember 3, 2025 | marketbeat.comPanagora Asset Management Inc. Purchases Shares of 141,162 Rhythm Pharmaceuticals, Inc. $RYTMSeptember 3, 2025 | marketbeat.comNorthern Trust Corp Sells 9,108 Shares of Rhythm Pharmaceuticals, Inc. $RYTMSeptember 2, 2025 | marketbeat.comRafferty Asset Management LLC Acquires 7,338 Shares of Rhythm Pharmaceuticals, Inc. $RYTMSeptember 1, 2025 | marketbeat.comCitizens JMP Keeps Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)September 1, 2025 | insidermonkey.comCitizens JMP Keeps Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)September 1, 2025 | uk.finance.yahoo.comRhythm Pharmaceuticals, Inc. $RYTM Shares Acquired by Driehaus Capital Management LLCAugust 31, 2025 | marketbeat.comSiren L.L.C. Acquires Shares of 277,533 Rhythm Pharmaceuticals, Inc. $RYTMAugust 31, 2025 | marketbeat.com Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RYTM Media Mentions By Week RYTM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RYTM News Sentiment▼1.090.77▲Average Medical News Sentiment RYTM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RYTM Articles This Week▼49▲RYTM Articles Average Week Get the Latest News and Ratings for RYTM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BioNTech News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Summit Therapeutics News Today Ascendis Pharma A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today Moderna News Today Roivant Sciences News Today QIAGEN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RYTM) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
